245 related articles for article (PubMed ID: 8914837)
1. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
[TBL] [Abstract][Full Text] [Related]
2. Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts.
Rao CN; Liu YY; Peavey CL; Woodley DT
Arch Biochem Biophys; 1995 Feb; 317(1):311-4. PubMed ID: 7872799
[TBL] [Abstract][Full Text] [Related]
3. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
[TBL] [Abstract][Full Text] [Related]
4. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
5. Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells.
Rao CN; Gomez DE; Woodley DT; Thorgeirsson UP
Arch Biochem Biophys; 1995 May; 319(1):55-62. PubMed ID: 7539605
[TBL] [Abstract][Full Text] [Related]
6. Characterization of native and recombinant bovine pregnancy-associated glycoproteins.
Patel OV; Takahashi T; Imai K; Hashizume K
Res Vet Sci; 2004 Dec; 77(3):203-10. PubMed ID: 15276771
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
Rao CN; Mohanam S; Puppala A; Rao JS
Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
[TBL] [Abstract][Full Text] [Related]
8. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
[TBL] [Abstract][Full Text] [Related]
9. Structure, function and biology of tissue factor pathway inhibitor-2.
Chand HS; Foster DC; Kisiel W
Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383
[TBL] [Abstract][Full Text] [Related]
10. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.
Iino M; Foster DC; Kisiel W
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):40-6. PubMed ID: 9445254
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells.
Toth M; Gervasi DC; Fridman R
Cancer Res; 1997 Aug; 57(15):3159-67. PubMed ID: 9242444
[TBL] [Abstract][Full Text] [Related]
12. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis pathway of gp90MEL-14, the mouse lymph node-specific homing receptor.
van de Rijn M; Weissman IL; Siegelman M
J Immunol; 1990 Sep; 145(5):1477-82. PubMed ID: 2166761
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity.
Zhu A; Wang ZK; Beavis R
Arch Biochem Biophys; 1998 Apr; 352(1):1-8. PubMed ID: 9521804
[TBL] [Abstract][Full Text] [Related]
15. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells.
Martinez-Lacaci I; Johnson GR; Salomon DS; Dickson RB
J Cell Physiol; 1996 Dec; 169(3):497-508. PubMed ID: 8952699
[TBL] [Abstract][Full Text] [Related]
17. Role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix.
Niedbala MJ; Madiyalakan R; Matta K; Crickard K; Sharma M; Bernacki RJ
Cancer Res; 1987 Sep; 47(17):4634-41. PubMed ID: 2957046
[TBL] [Abstract][Full Text] [Related]
18. cDNA cloning, expression, and characterization of an arylphorin-like hexameric storage protein, AgeHex2, from the mulberry longicorn beetle, Apriona germari.
Kim SR; Lee KS; Yoon HJ; Park NS; Lee SM; Je YH; Jin BR; Sohn HD
Arch Insect Biochem Physiol; 2004 Jun; 56(2):61-72. PubMed ID: 15146541
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of rainbow trout (Oncorhynchus mykiss) somatolactin cDNA and its expression in pituitary and nonpituitary tissues.
Yang BY; Arab M; Chen TT
Gen Comp Endocrinol; 1997 May; 106(2):271-80. PubMed ID: 9169123
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis.
Berleth ES; Nadadur S; Henn AD; Eppolito C; Shiojiri S; Gurtoo HL; Ehrke MJ; Mihich E
Cancer Res; 1999 Nov; 59(21):5497-506. PubMed ID: 10554026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
